PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd (formerly Amradeep Industries) reported zero revenue from operations for the second quarter and first half of FY26, with income coming only from 'Other Income' of Rs. 6.75 lakhs in Q2 and Rs. 13.11 lakhs in H1 FY26 (vs Rs. 18.80 lakhs for full FY25). Total expenses stood at Rs. 10.98 lakhs in Q2 and Rs. 18.15 lakhs in H1 FY26, resulting in a net loss of Rs. 4.23 lakhs for the quarter and Rs. 5.04 lakhs for the half year (compared to a profit of Rs. 0.57 lakhs in FY25). The balance sheet shows other equity in the negative at Rs. (127.75) lakhs, though shareholders' funds remain positive at Rs. 532.94 lakhs driven mainly by equity share capital of Rs. 660.69 lakhs. Operating cash flow was marginally positive at Rs. 7.02 lakhs, and statutory auditor Bipin & Co. issued an unqualified limited review report.
The company has no core operational revenue, is reporting losses, and carries negative accumulated reserves — a weak financial profile that could concern investors. However, the clean auditor's review and small scale mean this is unlikely to move the stock materially in the short term.